N/A Completed N=4,832 Randomized Health Services Research

An Evaluation of Post Discharge Utilization Among Patients With an Acute Exacerbation of COPD

Chronic Obstructive Pulmonary Disease

Source: ClinicalTrials.gov NCT03207776 ↗

Enrolled (actual)

4,832

Serious AEs

0.0%

Results posted

Oct 2019

Primary outcomePrimary: Healthcare Utilization — 1080; 920 Participants — p=0.041

Summary

Patients who are hospitalized at select Carolinas Healthcare System (CHS) sites with Chronic Obstructive Pulmonary Disorder (COPD) acute exacerbation symptoms will be treated per the CHS COPD Clinical Pathway. Patient outcomes will be followed, including but not limited to readmission. Patients on the pathway will also have access to navigator services.

Outcome Measures

Outcome	Result	p-value
PRIMARY Healthcare Utilization	1080; 920	0.041 sig
SECONDARY Quality, Comfort, and Care (QCC) Defined Readmission Rate	321; 286	0.952
SECONDARY Patient-centric (Protocol Defined) Readmission Rate	753; 659	0.472
SECONDARY 30-day COPD Specific, Acute Care Utilization to Any Hospital Within the System	240; 179	0.544

Eligibility Criteria

Inclusion Criteria

Identified as having an acute exacerbation of COPD within 24 hours of admission

Exclusion Criteria

Death during the index encounter
No initial discharge as of the end of the study period

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03207776). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.